Anixa Biosciences Inc
ANIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000715446
In the last 90 days, Anixa Biosciences Inc insiders filed 12 open-market purchases and 0 sales; 63 institutions reported holding it in 13F filings for Q2 2026, worth $15.0M in total; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $321.1K in total
- 12
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +3 vs. previous quarter
- 63
- 13F valueReported value at the end of Q2 2026
- $15.0M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding ANIX, Q2 2026
No superinvestor reported holding ANIX at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Anixa Biosciences Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 25, 2026 (view filing)8:39 AM ET | Sep 23 | 2 days | Titterton Lewis H jrDirector | PPurchase | +49.0K | $2.69 | +$131.9K | +4.9%1.05M after | |
| Sep 14, 2026 (view filing)9:45 AM ET | Sep 10 | 4 days | Kumar AmitChief Executive Officer | PPurchase | +3.00K | $2.75 | +$8.25K | +0.5%665.0K after | |
| Sep 14, 2026 (view filing)9:15 AM ET | Sep 10 | 4 days | Titterton Lewis H jrDirector | PPurchase | +10.0K | $2.73 | +$27.3K | +1.0%997.0K after | |
| Sep 11, 2026 (view filing)8:00 AM ET | Sep 10 | 1 day | Kumar AmitChief Executive Officer | PPurchase | +5.00K | $2.76 | +$13.8K | +0.8%662.0K after | |
| Aug 3, 2026 (view filing)8:45 AM ET | Jul 31 | 3 days | Kumar AmitChief Executive Officer | PPurchase | +5.00K | $3.47 | +$17.4K | +0.8%657.0K after | |
| Jul 28, 2026 (view filing)10:20 AM ET | Jul 27 | 1 day | Kumar AmitChief Executive Officer | PPurchase | +5.00K | $3.44 | +$17.2K | +0.8%652.0K after | |
| Jul 27, 2026 (view filing)3:25 PM ET | Jul 27 | Same day | Kumar AmitChief Executive Officer | PPurchase | +3.19K | $3.37 | +$10.7K | +0.5%647.0K after | |
| Jul 27, 2026 (view filing)9:00 AM ET | Jul 24 | 3 days | Kumar AmitChief Executive Officer | PPurchase | +3.00K | $3.73 | +$11.2K | +0.5%643.8K after | |
| Jul 21, 2026 (view filing)10:23 AM ET | Jul 20 | 1 day | Kumar AmitChief Executive Officer | PPurchase | +5.00K | $3.46 | +$17.3K | +0.8%640.8K after | |
| Jul 20, 2026 (view filing)6:19 PM ET | Jul 20 | Same day | Titterton Lewis H jrDirector | PPurchase | +12.0K | $3.47 | +$41.6K | +1.2%987.0K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Anixa Biosciences Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 1,329,852 | $3.72M | 0.00% | +14,870+1.1% | Added |
| UBS Group AG | 585,430 | $1.64M | 0.00% | +33,793+6.1% | Added |
| Laird Norton Trust Company, LLC | 578,727 | $1.62M | 0.03% | +12,400+2.2% | Added |
| D.A. Davidson & Co. | 539,272 | $1.51M | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 359,194 | $1.01M | 0.00% | −5,537−1.5% | Reduced |
| Marshall Wace, LLP | 328,332 | $919.3K | 0.00% | +155,153+89.6% | Added |
| BlackRock, Inc. | 199,755 | $559.3K | 0.00% | +29,652+17.4% | Added |
| Vanguard Fiduciary Trust Co | 192,356 | $538.6K | 0.00% | +1,282+0.7% | Added |
| State Street Corp | 159,040 | $445.3K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 117,465 | $329.0K | 0.02% | +18,623+18.8% | Added |